ATP 2016

SPACE - A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC J. Nyman et al. world lung 2015

102 patients,

(T1-2N0M0) NSCLC, significant comorbidity

9 Scandinavian centers

rando:

SBRT 3x 22 Gy; CFRT 35x 2 Gy

primary endpoint:

freedom from progression at 3 years

10 · 23. September